The largest database of trusted experimental protocols

24 protocols using adenosine triphosphate (atp)

1

Kinase Inhibition Assay with CLK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human CLK1 (50 ng, C57-11G, SignalChem Biotech Inc. Canada) was incubated with DMSO or a range of serial dilutions of 1C8 in kinase buffer (40 mM Tris–HCl pH 7.5, 25 mM MgCl2, 0.1 mg/mL BSA and 0.25 mM DTT) containing 50 µM of ATP (Promega, Madison, WI, USA). The 5 µL kinase reaction performed in 384-wells Bio-Rad white plate was incubated for 30 min at 30 °C. The reactions were stopped by adding 5 μL of ADP-Glo reagent (Promega, V6930) and incubated at room temperature for 40 min. After addition of 10 μL of Kinase Detection Reagent (Promega, V6930), plates were incubated for another 30 min at room temperature. Luminescence was measured with a plate-reading luminometer (integration time 750 ms/well). Data were analysed using GraphPad Prism version 8.3.0 (GraphPad Software, San Diego, California, USA).
+ Open protocol
+ Expand
2

Shank3 Phosphorylation by Kinases

Check if the same lab product or an alternative is used in the 5 most similar protocols
1 μg Shank3 fragment and 0.3 μg of active kinase (ERK2 [Sigma], PKAα [Millipore], GSKβ [SignalChem] or CK2α [SignalChem]) were mixed in 15 μl kinase reaction buffer (40 mM Tris-HCl pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 2 mM DTT and 100 μM ATP [Promega]) and incubated at 30 °C for 2 hr. The kinase reactions were terminated by addition of NuPAGE LDS sample buffer and sample reducing agent (Invitrogen) and boiled for 15 min. The boiled samples were subjected to mass spectrometry analysis.
+ Open protocol
+ Expand
3

EGFR Kinase Inhibition Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ADP-Glo™ kinase assay (Promega, Madison, WI) was used to screen Ibrutinib, WZ4002, CO1686, and AZD9291 for its EGFR inhibition effects. The kinase reaction system contains 4.95 μl EGFR (WT) (1.5 ng/μl), EGFR (T790M) (6 ng/μl) or EGFR (T790M/L858R) (1.5 ng/μl), 0.55 μl of serially diluted drug, and 5.5 μl EGFR substrate Poly (4:1 Glu, Tyr) peptide (0.2 μg/μl) (Promega, Madison, WI) with 40 μM ATP (Promega, Madison, WI). The reaction in each tube was started immediately by adding ATP and kept going for an hour under 37°C. After the tube cooled for 5 minutes at room temperature, 5 μl solvent reactions were carried out in a 384-well plate. Then 5 μl of ADP-Glo™ reagent was added into each well to stop the reaction and consume the remaining ADP within 40 minutes. At the end, 10 μl of kinase detection reagent was added into the well and incubated for 30 minutes to produce a luminescence signal. Luminescence signal was measured with an automated plate reader (Perkin-Elmer Envision) and each measurement was performed in triplicate.
+ Open protocol
+ Expand
4

Kinase Inhibition Screening of CHMFL-KIT-031

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ADP-Glo kinase assay (Promega, Madison, WI, USA) was used to screen CHMFL-KIT-031 for its c-KIT and the relevant mutations inhibition effects. The kinase reaction system contains 9 μL c-KIT (20 ng/μL) or c-KIT V559D (15 ng/μL), 1 μL of serially diluted CHMFL-KIT-031, and 10 μL substrate Poly (4:1 Glu, Tyr) peptide (0.4 μg/μL) (Promega, Madison, WI) with 100 μM ATP (Promega, Madison, WI). The reaction in each tube was started immediately by adding ATP and kept going for an hour under 37°C. After the tube cooled for 5 minutes at room temperature, 5 μL solvent reactions were carried out in a 384-well plate. Then 5 μL of ADP-Glo reagent was added into each well to stop the reaction and consume the remaining ATP within 40 minutes. At the end, 10 μL of kinase detection reagent was added into the well and incubated for 30 minutes to produce a luminescence signal. Luminescence signal was measured with an automated plate reader (Envision, PE, USA) and the dose-response curve was fitted using Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA). The biochemical tests of other targets were provided by Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand
5

CDK2 Kinase Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
One million Mo-MDSCs purified from bone marrow, spleen and tumour were lysed by cell lysis buffer (Cell Signaling Technology), and immunoprecipitated by anti-CDK2, and Protein A Dynabeads (Thermo Fisher Scientific). The antibodies are listed in Supplementary Data 4. For kinase reaction, precipitated CDK2 was incubated in 20 mM Tris-HCl (pH7.5) containing 5 ng/µl of recombinant SMAD3 (Sigma-Aldrich), 100 µM ATP (Promega), 0.1 mg/ml BSA, 1 mM DTT and 40 mM MgCl2 at 30 °C for 2 h. ATP to ADP conversion during kinase reaction was measured by ADP-Glo Kinase Assay (Promega) and Powerscan HT (DS Pharma Biomedical).
+ Open protocol
+ Expand
6

Phosphorylation of MLK3 by ULK1 Kinase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human MLK3 active protein (#M19–11G, SignalChem) was heat inactivated at 65°C for 20 min in a sonicating bath. To confirm heat inactivation of MLK3 recombinant protein, kinase reactions between MLK3 heat inactive protein (1 μg) and MBP substrate (5 μg) (#M42–51N, SignalChem) were performed. To determine whether ULK1 can directly phosphorylate MLK3, kinase reactions between recombinant human ULK1 active protein (100 ng) (#U01–11G, SignalChem) and MLK3 heat inactive protein (1.66 μg) were performed. As controls, the same kinase reactions were carried out, but using each recombinant protein alone. For each kinase reaction we used DTT (#D86–09B, SignalChem), ATP (#V915A, Promega), and 5x kinase buffer (#K03–09, SignalChem) following the manufacturer’s instructions. Kinase mixtures were incubated for 40 min shaking at 300 rpm and 30°C. The ADP formed from the kinase reactions was measured using the ADP-Glo Kinase Assay Kit (#V6930, Promega) following the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Recombinant human ALK kinase assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-terminal 6His tagged recombinant human ALK expressed in baculovirus Sf21 was purchased from EMD Millipore (Billerica, MA, USA) (purity ≥60% by sodium dodecyl sulfate polyacrylamide gel electrophoresis) and aliquoted to 1 μL fractions when it was used the first time (to avoid multiple freeze/thaws for subsequent experiments). BNP7787 was prepared by a proprietary method (purity >97%, no mesna was detected by mass spectroscopy). Kinase inhibitor, PF02341066 (crizotinib), was purchased from Selleck Chemicals, LLC. (Houston TX, USA). Polyglutamate-tyrosine (PolyGT) substrate was purchased from Sigma-Aldrich (St. Louis, MO, USA). Kinase assay buffer was prepared and consisted of 20 mM HEPES, 0.1% Brij 96, 10 mM NaF, 1 mM Na3VO4, and 10 mM MnCl2 adjusted to a final pH of 7.5. Half-area 96-well microplates were purchased directly from Corning Incorporated (Corning, NY, USA). ADP-Glo reagents were purchased from Promega (Madison WI, USA) and consisted of ADP, ATP, ADP-Glo, kinase detection reagent buffer, and kinase detection substrate. All other reagents were purchased from Sigma-Aldrich Co (St Louis, MO, USA). A Tecan Ultra microplate reader with XFluor software (V4.51; Tecan [Morrisville, NC, USA]) and RdrOle software (V4.50; Tecan) were used in this study.
+ Open protocol
+ Expand
8

IRES Activity Assay in shFBP1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
shFBP1-RD stable cells were grown to 90% confluence in DMEM. Cells were washed and scraped with PBS, and then pelleted by centrifugation at 300 × g for 10 minutes at 4°C. After discarding the supernatants, the cell pellets were resuspended in 1.5x pellet volume of hypotonic lysis buffer (10 mM HEPES-KOH, pH 7.6, 10 mM KOAc, 0.5 mM Mg(OAc)2, 2 mM DTT, and 1x protease inhibitor cocktail [Roche]), placed on ice for 30 minutes, and then homogenized with a 27-gauge 1/2-inch needle. Cell extracts were centrifuged at 10,000 × g for 20 minutes at 4°C, and the supernatants were recovered and stored at −80°C. In vitro IRES activity assays were performed in a final volume of 25 μl containing 0.25 μg EV71 5′ UTR-Luc reporter RNA, 60% volume of RD shFBP1 cell extracts, 10 mM creatine phosphate, 50 μg/ml creatine phosphokinase, 79 mM KOAc, 0.5 mM Mg(OAc)2, 2 mM DTT, 0.02 mM hemin, 0.5 mM spermidine, 20 mM HEPES-KOH (pH 7.6), 20 μM amino acid mixture (Promega), 0.4 mM ATP (Promega), and RNase inhibitor. The reactants were incubated at 30°C for 90 minutes, and firefly luciferase activity was measured using the luciferase assay system (Promega).
+ Open protocol
+ Expand
9

Luciferase Activity Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell extract representing the soluble protein fraction prepared from seedlings in luciferase assay buffer [20 mM Tricine, pH 7.8, 1.07 mM (MgCO3)4Mg(OH)2-5H2O, 2.67 mM MgSO4, 0.1 mM EDTA, 33.3 mM DTT, 270 μM CoA, and 500 μM ATP (Promega)], and the reaction was initiated with the injection of 100 μL of 0.5 mM luciferin in luciferase assay buffer. Photons were counted using a Monolight 2010 Luminometer (Analytical Luminescence Laboratory, San Diego, CA). Each mRNA construct was assayed in duplicate and the average is reported. Protein concentration was determined as described [94 (link)].
+ Open protocol
+ Expand
10

Syk Tyrosine Kinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reactions were carried out in a total volume of 25 μL in 96-well microtiter plates. The Syk tyrosine kinase activity at single dose concentration of 12.5 ng/μL, 10 μL of volume, was carried out served as the enzyme source. The total volume of 10 μL mixture containing 0.2 μg/μL Poly (Glu, Tyr) sodium salt (4:1, Glu:Tyr, Sigma–Aldrich, St. Louis, MO, USA) and 10 μM ATP (Promega, Madison, WI, USA) served as the standardized substrate. The concentration range of the tested inhibitors employed in reactions was 0.0032, 0.016, 0.08, 0.4, 2, 10 μM or DMSO with 5 μL volume. All of the enzymatic reactions were conducted at 37 °C for 60 min. The assay was terminated by adding 25 μL of ADP-GloTM Reagent (Promega, Madison, WI, USA). The 96-well plate was shaken and then incubated for 40 min at ambient temperature. Fifty microliter of Kinase detection reagent was added and the 96-well reaction plate was then read using the ADP-Glo Luminescences Protocol on a GloMax plate reader (Promega: Catalog #E7031). For each concentration of Vam3, the rate of reaction at each concentration of ATP was determined and plotted against the ATP concentration to determine the apparent Km and Vmax (maximal rate). Finally, the apparent Km (or apparent Km/Vmax) was plotted against the inhibitor concentration to determine the Ki. All data analysis was performed using Prism and Prism enzyme kinetics programs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!